Reporting a High-Producing Surgeon's Findings to a Resistant Medical Director

Exit conference (hold it before the report is issued, not after)

• State the scope and method first: 24 charts, which period, which code pairs, which guideline edition, who reviewed.
• Walk through two or three representative charts, not all seventeen. Give the provider the specific document he can respond to.
• Ask explicitly whether additional documentation exists anywhere - another system, the hospital record, a scanned op note. Some of these findings will dissolve if it does. Record the answer.
• Tell him what happens next and when, and that he will receive the full chart list with the report.

Written report structure

1. Purpose, scope, period, sample selection method
2. Criteria - the specific guideline and code-pair rules applied, with the reviewer's credentials
3. Findings by provider, each with claim identifiers and a one-sentence rationale
4. Quantification split into identified and extrapolated (see below)
5. Root cause
6. Corrective action plan with owners and due dates
7. Provider and management response, verbatim or summarized faithfully

Word choice

• Describe documents, not motives. Write 'the documentation does not support a high-complexity decision' - never 'the provider upcoded' or 'the provider overcharged.'
• Never use fraud, abuse, intentional, or pattern of misconduct in an internal audit report. Those are legal conclusions the auditor is not empowered to reach.
• Attribute clinical conclusions to the record: 'the note documents no decision regarding hospitalization or drug therapy requiring intensive monitoring.'

• Do not negotiate the finding in the meeting. Separate the finding from the response: the report states what the documentation supports; the medical director's disagreement goes into the report as a documented management response with its stated basis.
• Ask for the basis, in writing. Which specific charts, which clinical facts, which guideline language. 'The global nature of the visits' is a conclusion; the auditor needs the record facts that rebut the documentation analysis. If they exist, revise the finding - that is the system working.
• Offer independent peer review. A same-specialty, credentialed reviewer, blinded to the first reviewer's conclusions, on a subset of the disputed charts. This is the right mechanism for a genuine clinical disagreement, and it protects both parties.
• Name the conflict. The medical director's compensation is tied to this provider's production. That does not make him wrong, but it means he cannot be the final arbiter of the finding. Note it neutrally in the report and route the decision to the compliance committee, which is the body chartered to make it.
• Recognize the boundary of the auditor's authority too. The auditor rules on documentation support and coding, not on whether the care was good medicine. A peer reviewer may properly say the care was complex; the auditor's question is whether the record documents it.
• Never alter a finding because of who the provider is. If the report is softened and the underlying claims are later examined by a contractor, the softened report becomes the exhibit. Document the request and the response.

Report two numbers, clearly labeled, and explain what each one means.

1. Identified overpayment: $7,140 (17 claims)

• These specific claims have been reviewed and found unsupported at the billed level. This is not an estimate.
• For the Medicare portion, the 60-day repayment clock runs from the date the organization identified the overpayment - which is now, not when the expanded audit finishes. Advise the committee in writing of the date the clock started and let counsel manage the repayment or disclosure mechanics.
• For commercial claims, the obligation runs from the contract and the payer's policies, not the 60-day rule - so the auditor should say which portion of the $7,140 is Medicare and which is not.

2. Extrapolated exposure: not yet defensible

• 24 charts is far too small a base to project a repayment. A 71% error rate on 24 charts carries a confidence interval wide enough to make any annualized demand vulnerable to challenge.
• Before quoting an extrapolated figure, expand to a statistically valid random sample with the universe and methodology defined in advance, and have a second clinician validate the level determinations.
• If the expanded result is material, the committee needs counsel's view on whether reporting only the identified amount while holding a much larger estimate is defensible.

3. The recommendation the committee actually needs

• Repay the identified amount now, on the correct timeline, without waiting for the expanded audit.
• Approve the expanded sample and the pre-bill review of this provider's modifier-25 claims in the meantime, so the exposure stops growing.
• Do not let the size question delay the corrective action. The $7,140 is a small number; the run rate is not.